|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.60 CNY | -4.07% |
|
-3.26% | -16.33% |
| 05-08 | Tibet Rhodiola Pharmaceutical Holding's board elects chairman | RE |
| 04-28 | Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 11.33B 1.67B 1.46B 1.35B 1.26B 2.36B 157B 2.41B 16.18B 6.26B 77.67B 6.26B 6.12B 269B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.72B 1.28B 1.12B 1.04B 970M 1.82B 121B 1.86B 12.46B 4.82B 59.79B 4.82B 4.71B 207B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | -4.07% | ||
| 1 week | -3.26% | ||
| Current month | -7.63% | ||
| 1 month | -9.14% | ||
| 3 months | -11.46% | ||
| 6 months | -16.02% | ||
| Current year | -16.33% |
| 1 week | 35.52 |  | 38.66 |
| 1 month | 34.92 | | 39.06 |
| Current year | 34.92 | | 46 |
| 1 year | 34.92 | | 57.98 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 19/11/2014 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 24/10/2019 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 07/01/2015 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 07/01/2015 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 07/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.07% | -3.26% | -2.89% | -12.73% | 1.74B | |
| +6.28% | +8.56% | +50.47% | +164.25% | 1,006B | |
| +3.33% | +9.34% | +66.36% | +54.55% | 589B | |
| +1.72% | +7.43% | +32.29% | +83.11% | 430B | |
| -0.66% | +5.11% | +29.26% | +21.27% | 331B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | |
| +1.54% | +3.95% | +28.39% | +59.46% | 190B | |
| +1.67% | +0.78% | +16.94% | +64.38% | 154B | |
| Average | +1.16% | +4.75% | +26.73% | +46.23% | 348.75B | |
| Weighted average by Cap. | +2.85% | +5.37% | +39.19% | +78.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 413M 362M 333M 312M 585M 38.92B 598M 4.01B 1.55B 19.24B 1.55B 1.52B 66.7B | 2.98B 438M 384M 354M 332M 622M 41.35B 635M 4.26B 1.65B 20.43B 1.65B 1.61B 70.86B |
| Net income | 1.05B 155M 136M 125M 117M 219M 14.58B 224M 1.5B 581M 7.21B 580M 568M 24.98B | 938M 138M 121M 111M 104M 196M 13.01B 200M 1.34B 518M 6.43B 518M 506M 22.29B |
| Net Debt | -2.35B -346M -303M -279M -262M -490M -32.61B -501M -3.36B -1.3B -16.12B -1.3B -1.27B -55.88B | -2.61B -384M -336M -310M -290M -544M -36.18B -555M -3.73B -1.44B -17.88B -1.44B -1.41B -62B |
Employees
671
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | CN¥35.60 | -4.07% | 2,775,310 |
| 25/06/26 | CN¥37.11 | -1.12% | 3,067,835 |
| 24/06/26 | CN¥37.53 | -0.85% | 3,051,540 |
| 23/06/26 | CN¥37.85 | -0.13% | 3,993,874 |
| 22/06/26 | CN¥37.90 | +2.99% | 3,967,285 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
